Harold Chatelus is a Managing Director and a member of the CEEMEA Private Markets investment team. He is based in London.
Mr. Chatelus focuses on sourcing, evaluating, executing and monitoring investments across Europe. He currently serves on the Board of Directors of four portfolio companies, Pet Network International (Croatia), Optimapharm (Croatia), MyFamily (Italy) and Prestige (Bulgaria).
Prior to joining TRG in December 2013, he was a member of the Citi Venture Capital International (CVCI) investment team from 2011. At CVCI, Mr. Chatelus focused on investments in the pharmaceutical and retail sectors and served on the Board of Directors of three portfolio companies. Before CVCI, from 2008 to 2011, Mr. Chatelus was an Associate in Citi’s London-based Emerging Markets M&A team, advising clients across all industries on M&A transactions throughout the CEEMEA region. Prior to that, between 2006 and 2008, he was an Analyst in Citi’s Global Financial Institutions investment banking team, based in New York, where he advised clients on M&A transactions and debt and equity financing.
Mr. Chatelus holds a Bachelor of Science in Foreign Service (International Economics) from Georgetown University’s School of Foreign Service. He is fluent in French, Italian and Spanish.